Results 221 to 230 of about 53,892 (275)

mantle cell lymphoma

Annals of Oncology, 2008
openaire   +1 more source

Updates on the Biological Heterogeneity of Mantle Cell Lymphoma. [PDF]

Cancers (Basel)
Ip A, Kabat M, Fogel L, Alkhatatneh H, Voss J, Gupta A, Della Pia A, Leslie LA, Feldman T, Albitar M, Goy AH.   +10 more
europepmc   +1 more source

Advancing Mantle Cell Lymphoma Risk Assessment: Navigating a Moving Target. [PDF]

Hematol Oncol
Ferrero S, Ragaini S.
europepmc   +1 more source

SOX11 modulates BCR signaling through the PAX5/CD19 axis for therapeutic targeting in BTK-resistant mantle cell lymphoma. [PDF]

Blood Adv
Dutta RP, Lee HH, Leshchenko VV, Shukla RP, Yan F, Liu Y, Kaniskan HÜ, Qiu X, Jin J, Alinari L, Wang M, Parekh S.   +11 more
europepmc   +1 more source

Long-term outcomes of venetoclax and ibrutinib in Japanese patients with relapsed/refractory mantle cell lymphoma. [PDF]

Int J Clin Oncol
Goto H, Ito S, Kizaki M, Yamaguchi M, Fukuhara N, Kato K, Saito T, Terui Y, Soshin T, Satomi-Tsushita N, Honda H, Qian C, Izutsu K.   +12 more
europepmc   +1 more source

The SOX11:SMARCA4 complex is a driver of oncogenic transcriptional programs in mantle cell lymphoma. [PDF]

Blood Cancer J
De Bolòs A, Carreras-Caballé M, Sureda-Gómez M, Rodríguez ML, Charalampopoulou S, Albero R, Maiques-Diaz A, Playa-Albinyana H, Clot G, López C, Colomer D, Martin-Subero JI, Campo E, Reverter D, Villanueva J, Amador V.   +15 more
europepmc   +1 more source

Composite chronic lymphocytic leukemia and mantle cell lymphoma involving the bone marrow: a case report and literature review. [PDF]

J Pathol Transl Med
Demianets R, O'Brien S, Mahdavi K, Niu C, Aslam S, Tran T, Zhang Y, Gamayo A, Zhao X, Rezk SA.   +9 more
europepmc   +1 more source